deep margin

a head and neck oncology podcast with Ben O’Leary and Will Ince (@will_oncology)

[deep margin @deepmargin_pod]

Superstar Kevin Harrington joins us to discuss conference updates galore it’s a great summary of all the hot topics!
@DavidSherMD @drdavidpalma @HNSurgeon please RT and share! #hn #headandneck #hncsm

https://t.co/3ztXpAQewl

[deep margin @deepmargin_pod]

Great to put the latest episode out with the fabulous andrew Schache

https://t.co/tYkkfYWNI6

@drdavidpalma @DavidSherMD @ctdnaMD @VinPaleri

[deep margin @deepmargin_pod]

A foray into the Southern Hemisphere with the great Lockie Macdowell who talks us through #qol #PROs
amongst some really important trials - a great listen @kahutcheson @HNSurgeon @VinPaleri @DavidSherMD

https://t.co/GlzphN4mrO

[deep margin @deepmargin_pod]

Happy Monday! What a better way to spend a Monday morning commute than listening to the amazing Mererid Evans taking us through TNM9 and what it means for your practice. Please share!

https://t.co/bkn1qltb7S
@BAHNOOfficial
@will_oncology
@nearlobey
@DavidSherMD
@drdavidpalma

[David Sher @DavidSherMD]

The identification of the tubarial gland is a really cool story, though I am doubtful that TG-sparing radiotherapy will make a meaningful difference to patient-reported xerostomia.

Sparing the contralateral TG should already effectively be part of standard practice for ipsilateral-only nodal disease, and the ipsilateral TG will receive dose from elective treatment of the RP nodes.

We recently looked at patient-reported outcomes as a function of tubarial gland dose and could not find a significant relationship (and this included patients treated without ENI, so there was a truly variable dose to the TG):

https://t.co/Y579bM8J7A

[deep margin @deepmargin_pod]

POD alert!!!! Latest effort with @DrNeilGross talking to us about his work in the NMSC space - it's a belter.

https://t.co/kDgKGFcm7g

@VinPaleri @HNSurgeon @DrUppaluri @AriRosenbergMD @PBlanchardMD @drdavidpalma @DavidSherMD @oncodaily

[deep margin @deepmargin_pod]

The wonderful @PBlanchardMD joins us to discuss his latest trial and directions of travel in the p16 positive world

https://t.co/xu639MgbDr

@nearlobey

[deep margin @deepmargin_pod]

new episode alert! The wonderful Chris Holsinger @HNSurgeon joins us for his take on all things TORS.
#TORS #radonc #HNsurgery

@nearlobey @DavidSherMD @pierreblanchard
@GlennHarte1 @JeppeFriborgMD @kahutcheson @VinPaleri @DrUppaluri @drdavidpalma

https://t.co/GlQ0zMVLHJ

[deep margin @deepmargin_pod]

New episodes with @HeadNeckMD and @DrChrisNutting please check them out some important topics and more to come!

@nearlobey

https://t.co/GUBhiODW9w

[Vin Paleri @VinPaleri]

Pleased as punch to be invited onto the Deep Margin podcast, now a fixture in HN calendar.
Privilege to follow @DavidSherMD @DrUppaluri
Great fun chatting salvage surgery with @nearlobey @will_oncology Serious topic, yet an easy listen. Do tune in https://t.co/iztg4KsqUz

[David Sher @DavidSherMD]

I don't think I've ever had this much fun talking about radiotherapy.

We discussed ENI, immunotherapy (and radiotherapy) in metastatic and non-metastatic HNSCC, oligometastatic disease, to name a few.

[deep margin @deepmargin_pod]

New episode alert with the wonderful @DavidSherMD who talks us through the immunotherapy radiation paradigm….

https://t.co/BWuQl03zPH

[Pablo Jiménez @PaulJiL]

#ESMOAsia25

🚨JUPITER-02 Final 6-year OS analysis presented!

1L toripalimab + gem/cis in pts with RM-Nasopharyngeal Ca

Median OS 64.8 vs 33.7 mo
(HR 0.62; p<0.01)
Adjusted post-prog IO: 61.0 vs 25.1 mo (HR O.52)

Confirms long-term toriGP combo efficacy

��Updated situation of 1L NPC

@OncoAlert @brunolarvol #oncoalertAF
#NPC #Immunotherapy

[Ravi Uppaluri, MDPhD @DrUppaluri]

Had a lot of fun discussing perioperative trials in LA-HNSCC with @deepmargin_pod @will_oncology BenO'Leary !!! KEYNOTE-689, NIVOPOSTOP and future directions! @DrHaddadRobert @imrtlee @HeadNeckMD
https://t.co/VAVZpldgpl At end we discuss @jvuppaluri favorite @premierleague team!

[deep margin @deepmargin_pod]

https://t.co/NbWswdAXDR

[deep margin @deepmargin_pod]

new episodes out

Kevin Harrington on ESMO and Ravi Uppaluri on KN689/NIVOPOSTOP - spread the word! @DrUppaluri @PaulJiL @AriRosenbergMD @h_mehanna @HeadNeckMD

[BAHNO Head & Neck @BAHNOOfficial]

Meeting ID: 370 675 051 005 95
Passcode: yN62wT34
Please now join this webinar via Teams with details above.

[deep margin @deepmargin_pod]

Right we have arrived! Some absolutely great info in our first episode with the wonderful @AriRosenbergMD
https://t.co/cnl1QprSaH

[Dr sthanu subramanian @drsthanus]

"A Simplified Guide to the Immune System."

https://t.co/1SUZNqw7QG

[deep margin @deepmargin_pod]

@VinPaleri @HeadNeckMD

[deep margin @deepmargin_pod]

Episode 1 with the absolute legend @AriRosenbergMD discussing ADC data, nightclubs and military strategy https://t.co/IjUOdaOMAI